Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$12.63 USD

12.63
4,219,860

+0.42 (3.44%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $12.65 +0.02 (0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (230 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Iamgold (IAG) Acquires Common Shares of TomaGold for $2.5M

by Zacks Equity Research

Iamgold (IAG) completes its $2.5 million strategic investment in TomaGold.

    Zacks Equity Research

    Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company

    by Zacks Equity Research

    Zacks.com featured highlights: The Chemours Company, Haemonetics Corporation and The Brink's Company

      Zacks Equity Research

      AK Steel (AKS) Poised on Automotive Expansion Amid Headwinds

      by Zacks Equity Research

      While AK Steel (AKS) remains exposed to pricing and industry-related headwinds, it should gain from its efforts to grow its automotive business and improve cost structure.

        Zacks Equity Research

        Should You Get Rid of First Majestic Silver Corp. (AG) Now?

        by Zacks Equity Research

        First Majestic Silver Corp. (AG) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.

          Zacks Equity Research

          3 Best Stocks with Upgraded Broker Ratings to Invest In Now

          by Zacks Equity Research

          Selecting stocks from the vast investment universe is not an easy task. In such a situation, sound broker advice helps to pick the right stocks.

            Zacks Equity Research

            Nucor Corp (NUE) Scoops Up St. Louis Steel Bar Maker

            by Zacks Equity Research

            The buyout of St. Louis Cold Drawn is in sync with Nucor's (NUE) strategy to expand its position as the market leader in cold finished bar products.

              Zacks Equity Research

              ArcelorMittal to Invest 96M Euro in Florange and Dunkerque

              by Zacks Equity Research

              ArcelorMittal (MT) plans to invest 67 million euros in Florange for a new production line for automotive steels and 29 million euros at Dunkerque to attain greater flexibility for high value products.

                Zacks Equity Research

                Here's Why You Should Hold on to Andersons (ANDE) Stock Now

                by Zacks Equity Research

                The Andersons, Inc.'s (ANDE) Grain and Ethanol Groups are anticipated to have a better second half. However, oversupply issues in the Plant Nutrient & Rail Groups remain headwinds.

                  Zacks Equity Research

                  Iamgold (IAG) Posts in-Line Earnings in Q2, Sales Rise Y/Y

                  by Zacks Equity Research

                  Iamgold (IAG) swung to a profit on a reported basis in Q2 on the back of operational improvements and increased sales.

                    Zacks Equity Research

                    Kronos Worldwide (KRO) Misses on Q2 Earnings, Sales Up Y/Y

                    by Zacks Equity Research

                    Kronos Worldwide (KRO) recorded year-over-year growth in earnings in second-quarter 2017 on the back of higher income from operations.

                      David Bartosiak headshot

                      5 Strong Buy Stocks Surging Again

                      by David Bartosiak

                      Familiar stocks to buy are surging through new highs

                        Tirthankar Chakraborty headshot

                        New Strong Buy Stocks for August 8th

                        by Tirthankar Chakraborty

                        Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                          Zacks Equity Research

                          American Vanguard (AVD) Q2 Earnings & Sales Beat Estimates

                          by Zacks Equity Research

                          Strong demand and cost control actions drove American Vanguard's (AVD) second-quarter earnings.

                            Zacks Equity Research

                            Century Aluminum (CENX) Q2 Earnings & Sales Trail Estimates

                            by Zacks Equity Research

                            Century Aluminum (CENX) swung to a profit in Q2 on a gain related to forward and derivative contracts, but its earnings missed expectations.

                              Zacks Equity Research

                              What's in Cards for Univar (UNVR) this Earnings Season?

                              by Zacks Equity Research

                              Univar's (UNVR) Q2 earnings is likely to benefit from its margin management and productivity initiatives.

                                Zacks Equity Research

                                U.S. Silica's (SLCA) Q2 Earnings Beat Estimates, Sales Trail

                                by Zacks Equity Research

                                Strong demand and higher pricing for frac sand helped U.S. Silica (SLCA) beat earnings expectations in Q2.

                                  Zacks Equity Research

                                  3 Chemical Stocks Set For an Earnings Beat in Q2

                                  by Zacks Equity Research

                                  The prospects for the U.S. chemical industry looks bright.

                                    Zacks Equity Research

                                    Is Westlake Chemical (WLK) Poised for a Beat in Q2 Earnings?

                                    by Zacks Equity Research

                                    Westlake Chemical's (WLK) second-quarter 2017 earnings are expected to benefit from strong global demand and pricing initiatives.

                                      Zacks Equity Research

                                      What's in Store for Century Aluminum (CENX) in Q2 Earnings?

                                      by Zacks Equity Research

                                      Century Aluminum's (CENX) second-quarter results are likely to benefit from strong aluminum demand amid a difficult pricing environment.

                                        Zacks Equity Research

                                        Should You Buy The Chemours (CC) Ahead of Earnings?

                                        by Zacks Equity Research

                                        The Chemours (CC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                          Zacks Equity Research

                                          CF Industries (CF) Q2 Earnings Preview: Stock to Disappoint?

                                          by Zacks Equity Research

                                          Continued pricing pressure may hurt CF Industries' (CF) second-quarter results.

                                            Zacks Equity Research

                                            What's in the Cards for Cabot Corp (CBT) in Q3 Earnings?

                                            by Zacks Equity Research

                                            Cabot Corp.'s (CBT) third-quarter fiscal 2017 earnings are likely to gain from strong demand of Performance Chemicals' end markets amid higher feedstock costs.

                                              Zacks Equity Research

                                              Mosaic (MOS) to Report Q2 Earnings: What's in the Cards?

                                              by Zacks Equity Research

                                              Cost-reduction measures and improved demand are expected to support Q2 results of Mosaic (MOS).

                                                Zacks Equity Research

                                                Can the Rally in Chemours (CC) Shares Continue?

                                                by Zacks Equity Research

                                                The Chemours Company (CC) has been on the move lately as the stock has risen by 29.7% in the past four weeks, and it is currently trading well above its 20-Day SMA

                                                  Zacks Equity Research

                                                  What's in the Cards for U.S. Silica (SLCA) in Q2 Earnings?

                                                  by Zacks Equity Research

                                                  U.S. Silica (SLCA) is likely to benefit from Sandbox Enterprises acquisition in Q2 amid capacity shortage of sand proppant demand.